Overview of the regulation of the class IA PI3K/AKT pathway by SUMO

被引：26
|
作者：
Vidal, Santiago [1 ]
Bouzaher, Yanis Hichem [1 ]
El Motiam, Ahmed [1 ,2 ,3 ]
Seoane, Rocio [1 ]
Rivas, Carmen [1 ,4 ]
机构：
[1] Univ Santiago De Compostela, Ctr Invest Med Mol & Enfermedades Cronicas CIMUS, Inst Invest Sanit IDIS, Santiago De Compostela 15706, Spain
[2] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Dept Ophthalmol & Vis Sci,Sinai Hlth Syst, Toronto, ON M5G 1X5, Canada
[3] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada
[4] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada
来源：
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY | 2022年 / 132卷
关键词：
SUMO; PI3K; p85; p110; AKT; PTEN; NF-KAPPA-B; CELL-CYCLE PROGRESSION; PROTEIN-KINASE-B; E3; LIGASE; TUMOR-SUPPRESSOR; PHOSPHATIDYLINOSITOL; 3-KINASE; TYROSINE PHOSPHORYLATION; EMERGING MECHANISMS; RELA/P65; SUBUNIT; TOPORS FUNCTIONS;
D O I：
10.1016/j.semcdb.2021.10.012
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The phosphatidylinositol-3-kinase (PI3K)/AKT pathway is a major regulator of metabolism, migration, survival, proliferation, and antiviral immunity. Both an overactivation and an inhibition of the PI3K/AKT pathway are related to different pathologies. Activation of this signaling pathway is tightly controlled through a multistep process and its deregulation can be associated with aberrant post-translational modifications including SUMOylation. Here, we review the complex modulation of the PI3K/AKT pathway by SUMOylation and we discuss its putative incvolvement in human disease.
引用
收藏
页码：51 / 61
页数：11
相关论文
共 50 条
  • [1] Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
    Kawauchi, Kiyotaka
    Ogasawara, Toshie
    Yasuyama, Masako
    Otsuka, Kuniaki
    Yamada, Osamu
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (09) : 1024 - 1038
  • [2] The PI3K/AKT Pathway and Renal Cell Carcinoma
    Guo, Huifang
    German, Peter
    Bai, Shanshan
    Barnes, Sean
    Guo, Wei
    Qi, Xiangjie
    Lou, Hongxiang
    Liang, Jiyong
    Jonasch, Eric
    Mills, Gordon B.
    Ding, Zhiyong
    JOURNAL OF GENETICS AND GENOMICS, 2015, 42 (07) : 343 - 353
  • [3] The PI3K/AKT cell signaling pathway is involved in regulation of osteoporosis
    Xi, Jian-Cheng
    Zang, Hai-Yu
    Guo, Li-Xin
    Xue, Hai-Bin
    Liu, Xiang-Dong
    Bai, Yi-Bing
    Ma, Yuan-Zheng
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2015, 35 (06) : 640 - 645
  • [4] The interplay of ROS and the PI3K/Akt pathway in autophagy regulation
    Kma, Lakhan
    Baruah, Taranga Jyoti
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2022, 69 (01) : 248 - 264
  • [5] PI3K/Akt Pathway: A Potential Therapeutic Target for Chronic Pain
    Chen, Shu-Ping
    Zhou, Ya-Qun
    Liu, Dai-Qiang
    Zhang, Wen
    Manyande, Anne
    Guan, Xue-Hai
    Tian, Yu-Ke
    Ye, Da-Wei
    Omar, Deeq Mohamed
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (12) : 1860 - 1868
  • [6] Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
    Li, Huayi
    Prever, Lorenzo
    Hirsch, Emilio
    Gulluni, Federico
    CANCERS, 2021, 13 (14)
  • [7] Divergent roles of the regulatory subunits of class IA PI3K
    Kim, Cho-Won
    Lee, Junsik M.
    Park, Sang Won
    FRONTIERS IN ENDOCRINOLOGY, 2024, 14
  • [8] RICTOR involvement in the PI3K/AKT pathway regulation in melanocytes and melanoma
    Laugier, Florence
    Finet-Benyair, Adeline
    Andre, Jocelyne
    Rachakonda, P. Sivaramakrishna
    Kumar, Rajiv
    Bensussan, Armand
    Dumaz, Nicolas
    ONCOTARGET, 2015, 6 (29) : 28120 - 28131
  • [9] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [10] Regulation of survivin by PI3K/Akt/p70S6K1 pathway
    Zhao, Peng
    Meng, Qiao
    Liu, Ling-Zhi
    You, You-Ping
    Liu, Ning
    Jiang, Bing-Hua
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 395 (02) : 219 - 224
12345